Molecular pathogenesis of transplacentally induced mouse lung tumors

Mark Steven Miller, Sandra Leone-Kabler, Lisa A. Rollins, Lisa L. Wessner, Manxia Fan, Dorcas O. Schaeffer, Michael F. McEntee, M. Gerard O'Sullivan

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Previous studies from this and other laboratories have shown that treatment of pregnant mice with 3-methylcholanthrene (MC) caused lung tumors in the offspring, the incidence of which correlated with fetal inducibility of Cyp1a1. Analysis of paraffin-embedded lung tissue for Ki-ras-2 mutations indicated that 79% of the lesions examined contained point mutations in codons 12 and 13 of the Ki-ras-2 gene locus, the majority of which (84%) were G → T transversions. The mutational spectrum was dependent on the tumor stage, as both the incidence of mutation and type of mutation produced correlated with malignant progression of the tumor. Mutations occurred in 60% of the hyperplasias, 80% of the adenomas, and 100% of the adenocarcinomas. In the tumors with mutations, GLY12 → CYS12 transversions occurred in 100% of the hyperplasias, 42% of the adenomas, and 14% of the adenocarcinomas. GLY12 → VAL12 transversions were not observed in hyperplasias and occurred in 42% of the ade- nomas and 57% of the adenocarcinomas. The remaining ASP12 and ARG13 mutations occurred only in adenomas (17%) and adenocarcinomas (29%). The tumors were also analyzed for alterations in the structure or function of the tumor suppressor genes Rb, p53, and Cdkn2a. No mutations were observed in exons 5-8 of the p53 gene. SSCP analysis demonstrated that 2 of 15 lung tumors contained shifted bands at the Cdkn2a gene locus. Sequence analysis has identified these as mutations in exon 2, with a CAC → TAC transition at base 301 (HIS74 → TYR74) in tumor 23-1 and GGG → GAG transition at base 350 (GLY90 → GLU90) in tumor 36-1. Northern blot analysis of the larger tumors revealed that 14 of 14 of these large lung tumors exhibited markedly decreased expression of Rb gene transcripts. These results were confirmed by immunohistochemistry. The larger tumors, which exhibited features of adenocarcinomas, showed a marked reduction or almost complete absence of nuclear pRb staining compared with smaller adenomas and normal lung tissue. The results suggest that Ki-ras-2 mutations are an early and frequent event in lung tumorigenesis, and that the type of mutation produced by environmental chemicals can influence the carcinogenic potential of the tumor. The results obtained with the Cdkn2a and Rb genes suggest that alterations in the Rb regulatory axis may play a key role in the pathogenesis of the pulmonary tumors and appear to occur later in the neoplastic process. It appears from these experiments that the combination of mutated Ki-ras-2 and alterations in the Rb regulatory gene locus, which are frequent alterations in human lung tumors, may be the preferred pathway for lung tumor pathogenesis in mice exposed transplacentally to environmental carcinogens.

Original languageEnglish (US)
Pages (from-to)557-577
Number of pages21
JournalExperimental Lung Research
Volume24
Issue number4
DOIs
StatePublished - Jan 1 1998

Fingerprint

Tumors
Lung
Neoplasms
Mutation
Genes
Adenoma
Retinoblastoma Genes
Adenocarcinoma
Hyperplasia
Exons
Environmental Carcinogens
Neoplastic Processes
Tissue
Single-Stranded Conformational Polymorphism
Methylcholanthrene
ras Genes
Incidence
p53 Genes
Regulator Genes
Tumor Suppressor Genes

Keywords

  • Cdkn2a
  • Fetus
  • Ki-ras-2
  • Lung cancer
  • Oncogenes
  • Retinoblastoma
  • Tumor suppression genes

Cite this

Miller, M. S., Leone-Kabler, S., Rollins, L. A., Wessner, L. L., Fan, M., Schaeffer, D. O., ... O'Sullivan, M. G. (1998). Molecular pathogenesis of transplacentally induced mouse lung tumors. Experimental Lung Research, 24(4), 557-577. https://doi.org/10.3109/01902149809087386

Molecular pathogenesis of transplacentally induced mouse lung tumors. / Miller, Mark Steven; Leone-Kabler, Sandra; Rollins, Lisa A.; Wessner, Lisa L.; Fan, Manxia; Schaeffer, Dorcas O.; McEntee, Michael F.; O'Sullivan, M. Gerard.

In: Experimental Lung Research, Vol. 24, No. 4, 01.01.1998, p. 557-577.

Research output: Contribution to journalArticle

Miller, MS, Leone-Kabler, S, Rollins, LA, Wessner, LL, Fan, M, Schaeffer, DO, McEntee, MF & O'Sullivan, MG 1998, 'Molecular pathogenesis of transplacentally induced mouse lung tumors', Experimental Lung Research, vol. 24, no. 4, pp. 557-577. https://doi.org/10.3109/01902149809087386
Miller MS, Leone-Kabler S, Rollins LA, Wessner LL, Fan M, Schaeffer DO et al. Molecular pathogenesis of transplacentally induced mouse lung tumors. Experimental Lung Research. 1998 Jan 1;24(4):557-577. https://doi.org/10.3109/01902149809087386
Miller, Mark Steven ; Leone-Kabler, Sandra ; Rollins, Lisa A. ; Wessner, Lisa L. ; Fan, Manxia ; Schaeffer, Dorcas O. ; McEntee, Michael F. ; O'Sullivan, M. Gerard. / Molecular pathogenesis of transplacentally induced mouse lung tumors. In: Experimental Lung Research. 1998 ; Vol. 24, No. 4. pp. 557-577.
@article{84cace32702a400e8f3e123d040b720d,
title = "Molecular pathogenesis of transplacentally induced mouse lung tumors",
abstract = "Previous studies from this and other laboratories have shown that treatment of pregnant mice with 3-methylcholanthrene (MC) caused lung tumors in the offspring, the incidence of which correlated with fetal inducibility of Cyp1a1. Analysis of paraffin-embedded lung tissue for Ki-ras-2 mutations indicated that 79{\%} of the lesions examined contained point mutations in codons 12 and 13 of the Ki-ras-2 gene locus, the majority of which (84{\%}) were G → T transversions. The mutational spectrum was dependent on the tumor stage, as both the incidence of mutation and type of mutation produced correlated with malignant progression of the tumor. Mutations occurred in 60{\%} of the hyperplasias, 80{\%} of the adenomas, and 100{\%} of the adenocarcinomas. In the tumors with mutations, GLY12 → CYS12 transversions occurred in 100{\%} of the hyperplasias, 42{\%} of the adenomas, and 14{\%} of the adenocarcinomas. GLY12 → VAL12 transversions were not observed in hyperplasias and occurred in 42{\%} of the ade- nomas and 57{\%} of the adenocarcinomas. The remaining ASP12 and ARG13 mutations occurred only in adenomas (17{\%}) and adenocarcinomas (29{\%}). The tumors were also analyzed for alterations in the structure or function of the tumor suppressor genes Rb, p53, and Cdkn2a. No mutations were observed in exons 5-8 of the p53 gene. SSCP analysis demonstrated that 2 of 15 lung tumors contained shifted bands at the Cdkn2a gene locus. Sequence analysis has identified these as mutations in exon 2, with a CAC → TAC transition at base 301 (HIS74 → TYR74) in tumor 23-1 and GGG → GAG transition at base 350 (GLY90 → GLU90) in tumor 36-1. Northern blot analysis of the larger tumors revealed that 14 of 14 of these large lung tumors exhibited markedly decreased expression of Rb gene transcripts. These results were confirmed by immunohistochemistry. The larger tumors, which exhibited features of adenocarcinomas, showed a marked reduction or almost complete absence of nuclear pRb staining compared with smaller adenomas and normal lung tissue. The results suggest that Ki-ras-2 mutations are an early and frequent event in lung tumorigenesis, and that the type of mutation produced by environmental chemicals can influence the carcinogenic potential of the tumor. The results obtained with the Cdkn2a and Rb genes suggest that alterations in the Rb regulatory axis may play a key role in the pathogenesis of the pulmonary tumors and appear to occur later in the neoplastic process. It appears from these experiments that the combination of mutated Ki-ras-2 and alterations in the Rb regulatory gene locus, which are frequent alterations in human lung tumors, may be the preferred pathway for lung tumor pathogenesis in mice exposed transplacentally to environmental carcinogens.",
keywords = "Cdkn2a, Fetus, Ki-ras-2, Lung cancer, Oncogenes, Retinoblastoma, Tumor suppression genes",
author = "Miller, {Mark Steven} and Sandra Leone-Kabler and Rollins, {Lisa A.} and Wessner, {Lisa L.} and Manxia Fan and Schaeffer, {Dorcas O.} and McEntee, {Michael F.} and O'Sullivan, {M. Gerard}",
year = "1998",
month = "1",
day = "1",
doi = "10.3109/01902149809087386",
language = "English (US)",
volume = "24",
pages = "557--577",
journal = "Experimental Lung Research",
issn = "0190-2148",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Molecular pathogenesis of transplacentally induced mouse lung tumors

AU - Miller, Mark Steven

AU - Leone-Kabler, Sandra

AU - Rollins, Lisa A.

AU - Wessner, Lisa L.

AU - Fan, Manxia

AU - Schaeffer, Dorcas O.

AU - McEntee, Michael F.

AU - O'Sullivan, M. Gerard

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Previous studies from this and other laboratories have shown that treatment of pregnant mice with 3-methylcholanthrene (MC) caused lung tumors in the offspring, the incidence of which correlated with fetal inducibility of Cyp1a1. Analysis of paraffin-embedded lung tissue for Ki-ras-2 mutations indicated that 79% of the lesions examined contained point mutations in codons 12 and 13 of the Ki-ras-2 gene locus, the majority of which (84%) were G → T transversions. The mutational spectrum was dependent on the tumor stage, as both the incidence of mutation and type of mutation produced correlated with malignant progression of the tumor. Mutations occurred in 60% of the hyperplasias, 80% of the adenomas, and 100% of the adenocarcinomas. In the tumors with mutations, GLY12 → CYS12 transversions occurred in 100% of the hyperplasias, 42% of the adenomas, and 14% of the adenocarcinomas. GLY12 → VAL12 transversions were not observed in hyperplasias and occurred in 42% of the ade- nomas and 57% of the adenocarcinomas. The remaining ASP12 and ARG13 mutations occurred only in adenomas (17%) and adenocarcinomas (29%). The tumors were also analyzed for alterations in the structure or function of the tumor suppressor genes Rb, p53, and Cdkn2a. No mutations were observed in exons 5-8 of the p53 gene. SSCP analysis demonstrated that 2 of 15 lung tumors contained shifted bands at the Cdkn2a gene locus. Sequence analysis has identified these as mutations in exon 2, with a CAC → TAC transition at base 301 (HIS74 → TYR74) in tumor 23-1 and GGG → GAG transition at base 350 (GLY90 → GLU90) in tumor 36-1. Northern blot analysis of the larger tumors revealed that 14 of 14 of these large lung tumors exhibited markedly decreased expression of Rb gene transcripts. These results were confirmed by immunohistochemistry. The larger tumors, which exhibited features of adenocarcinomas, showed a marked reduction or almost complete absence of nuclear pRb staining compared with smaller adenomas and normal lung tissue. The results suggest that Ki-ras-2 mutations are an early and frequent event in lung tumorigenesis, and that the type of mutation produced by environmental chemicals can influence the carcinogenic potential of the tumor. The results obtained with the Cdkn2a and Rb genes suggest that alterations in the Rb regulatory axis may play a key role in the pathogenesis of the pulmonary tumors and appear to occur later in the neoplastic process. It appears from these experiments that the combination of mutated Ki-ras-2 and alterations in the Rb regulatory gene locus, which are frequent alterations in human lung tumors, may be the preferred pathway for lung tumor pathogenesis in mice exposed transplacentally to environmental carcinogens.

AB - Previous studies from this and other laboratories have shown that treatment of pregnant mice with 3-methylcholanthrene (MC) caused lung tumors in the offspring, the incidence of which correlated with fetal inducibility of Cyp1a1. Analysis of paraffin-embedded lung tissue for Ki-ras-2 mutations indicated that 79% of the lesions examined contained point mutations in codons 12 and 13 of the Ki-ras-2 gene locus, the majority of which (84%) were G → T transversions. The mutational spectrum was dependent on the tumor stage, as both the incidence of mutation and type of mutation produced correlated with malignant progression of the tumor. Mutations occurred in 60% of the hyperplasias, 80% of the adenomas, and 100% of the adenocarcinomas. In the tumors with mutations, GLY12 → CYS12 transversions occurred in 100% of the hyperplasias, 42% of the adenomas, and 14% of the adenocarcinomas. GLY12 → VAL12 transversions were not observed in hyperplasias and occurred in 42% of the ade- nomas and 57% of the adenocarcinomas. The remaining ASP12 and ARG13 mutations occurred only in adenomas (17%) and adenocarcinomas (29%). The tumors were also analyzed for alterations in the structure or function of the tumor suppressor genes Rb, p53, and Cdkn2a. No mutations were observed in exons 5-8 of the p53 gene. SSCP analysis demonstrated that 2 of 15 lung tumors contained shifted bands at the Cdkn2a gene locus. Sequence analysis has identified these as mutations in exon 2, with a CAC → TAC transition at base 301 (HIS74 → TYR74) in tumor 23-1 and GGG → GAG transition at base 350 (GLY90 → GLU90) in tumor 36-1. Northern blot analysis of the larger tumors revealed that 14 of 14 of these large lung tumors exhibited markedly decreased expression of Rb gene transcripts. These results were confirmed by immunohistochemistry. The larger tumors, which exhibited features of adenocarcinomas, showed a marked reduction or almost complete absence of nuclear pRb staining compared with smaller adenomas and normal lung tissue. The results suggest that Ki-ras-2 mutations are an early and frequent event in lung tumorigenesis, and that the type of mutation produced by environmental chemicals can influence the carcinogenic potential of the tumor. The results obtained with the Cdkn2a and Rb genes suggest that alterations in the Rb regulatory axis may play a key role in the pathogenesis of the pulmonary tumors and appear to occur later in the neoplastic process. It appears from these experiments that the combination of mutated Ki-ras-2 and alterations in the Rb regulatory gene locus, which are frequent alterations in human lung tumors, may be the preferred pathway for lung tumor pathogenesis in mice exposed transplacentally to environmental carcinogens.

KW - Cdkn2a

KW - Fetus

KW - Ki-ras-2

KW - Lung cancer

KW - Oncogenes

KW - Retinoblastoma

KW - Tumor suppression genes

UR - http://www.scopus.com/inward/record.url?scp=0031804265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031804265&partnerID=8YFLogxK

U2 - 10.3109/01902149809087386

DO - 10.3109/01902149809087386

M3 - Article

VL - 24

SP - 557

EP - 577

JO - Experimental Lung Research

JF - Experimental Lung Research

SN - 0190-2148

IS - 4

ER -